150 related articles for article (PubMed ID: 37231873)
1. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
[TBL] [Abstract][Full Text] [Related]
2. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
4. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.
Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV
J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633
[TBL] [Abstract][Full Text] [Related]
5. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus.
Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N
J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
[TBL] [Abstract][Full Text] [Related]
9. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo.
Refat MA; Strassner JP; Frisoli ML; Rashighi M; Richmond J; Nada E; Saleh R; El-Hamd MA; Goldberg D; Mahmoud BH; Harris JE
J Invest Dermatol; 2023 Nov; 143(11):2275-2282.e6. PubMed ID: 37478900
[TBL] [Abstract][Full Text] [Related]
10. Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.
Narayan VS; van den Bol LLC; van Geel N; Bekkenk MW; Luiten RM; Wolkerstorfer A
J Eur Acad Dermatol Venereol; 2021 May; 35(5):1077-1086. PubMed ID: 33428279
[TBL] [Abstract][Full Text] [Related]
11. Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO
Lommerts JE; Meesters AA; Komen L; Bekkenk MW; de Rie MA; Luiten RM; Wolkerstorfer A
Br J Dermatol; 2017 Nov; 177(5):1293-1298. PubMed ID: 28403523
[TBL] [Abstract][Full Text] [Related]
12. Impact of graft cell density and viability on repigmentation upon noncultured autologous cell suspension transplantation in vitiligo and piebaldism.
Uitentuis SE; Willemsen KJ; Lommerts JE; Komen L; Tjin EPM; Bekkenk MW; Wolkerstorfer A; Luiten RM
Clin Exp Dermatol; 2020 Oct; 45(7):907-908. PubMed ID: 32311146
[No Abstract] [Full Text] [Related]
13. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.
Ramos MG; Ramos DG; Ramos CG
An Bras Dermatol; 2017; 92(3):312-318. PubMed ID: 29186240
[TBL] [Abstract][Full Text] [Related]
14. Fractional versus full ablative CO
Jamal-Edine AM; El-Barbary RA; Moftah NH
J Cosmet Dermatol; 2022 Apr; 21(4):1506-1513. PubMed ID: 34213808
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
16. Simplified cellular grafting for treatment of vitiligo and piebaldism: the "6-well plate" technique.
Goh BK; Chua XM; Chong KL; de Mil M; van Geel NA
Dermatol Surg; 2010 Feb; 36(2):203-7. PubMed ID: 20039922
[TBL] [Abstract][Full Text] [Related]
17. Dermabrasion Versus Microneedling in Transplantation of Autologous Noncultured Melanocyte-Keratinocyte Cell Suspension in Patients With Vitiligo.
Hasan MS; Almohsen AM; Nasr MI; Rageh MA
Dermatol Surg; 2023 May; 49(5):494-502. PubMed ID: 36892550
[TBL] [Abstract][Full Text] [Related]
18. Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study.
El Hawary M; Bassiouny DA; Esmat S; Sobhi R; Saleh MA; AbdelHalim D; Hegazy R; Gawdat H; Ragab N; Samir N; Sany I
Dermatol Ther; 2020 Nov; 33(6):e14199. PubMed ID: 32798282
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Transplantation of Combination of Noncultured Dermal and Epidermal Cell Suspension vs Epidermal Cell Suspension Alone in Vitiligo: A Randomized Clinical Trial.
Thakur V; Kumar S; Kumaran MS; Kaushik H; Srivastava N; Parsad D
JAMA Dermatol; 2019 Feb; 155(2):204-210. PubMed ID: 30601885
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.
Olsson MJ; Juhlin L
Br J Dermatol; 2002 Nov; 147(5):893-904. PubMed ID: 12410698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
